U.S. markets closed
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • Dow 30

    30,814.26
    -177.24 (-0.57%)
     
  • Nasdaq

    12,998.50
    -114.10 (-0.87%)
     
  • Russell 2000

    2,123.20
    -32.15 (-1.49%)
     
  • Crude Oil

    52.24
    -0.12 (-0.23%)
     
  • Gold

    1,833.50
    +3.60 (+0.20%)
     
  • Silver

    24.97
    +0.10 (+0.42%)
     
  • EUR/USD

    1.2070
    -0.0015 (-0.12%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • GBP/USD

    1.3549
    -0.0035 (-0.26%)
     
  • USD/JPY

    103.7560
    -0.0440 (-0.04%)
     
  • BTC-USD

    36,921.69
    +862.80 (+2.39%)
     
  • CMC Crypto 200

    716.06
    -19.08 (-2.60%)
     
  • FTSE 100

    6,725.41
    -10.30 (-0.15%)
     
  • Nikkei 225

    28,242.21
    -276.97 (-0.97%)
     

Bio-techne Corp (TECH) CFO James Hippel Sold $3.3 million of Shares

GuruFocus.com
·1 min read

- By insider

CFO of Bio-techne Corp (30-Year Financial, Insider Trades) James Hippel (insider trades) sold 10,000 shares of TECH on 01/11/2021 at an average price of $333.63 a share. The total sale was $3.3 million.


Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products. Bio-Techne Corp has a market cap of $12.76 billion; its shares were traded at around $330.580000 with a P/E ratio of 52.86 and P/S ratio of 17.25. The dividend yield of Bio-Techne Corp stocks is 0.38%. Bio-Techne Corp had annual average EBITDA growth of 4.70% over the past ten years. GuruFocus rated Bio-Techne Corp the business predictability rank of 3.5-star. GuruFocus has detected 2 severe warning signs with Bio-Techne Corp. .

CFO Recent Trades:

  • CFO James Hippel sold 10,000 shares of TECH stock on 01/11/2021 at the average price of $333.63. The price of the stock has decreased by 0.91% since.

For the complete insider trading history of TECH, click here

.This article first appeared on GuruFocus.